Clinical Trial Update: Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years [Phase 1]

View source ↗

Summary

A Phase 1 trial assessed a single vaccination with the four-antigen Staphylococcus aureus vaccine SA4Ag in healthy adults aged 18 to under 65; the study has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Infections

Drugs mentioned

• SA4Ag (4-antigen Staphylococcus aureus vaccine)

Snippet

Sponsor: Pfizer | Conditions: Staphylococcal Infections | Phase 1 | Status: COMPLETED